Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Qiagen N.V. (QGEN)
USD41.59
+0.03 (+0.06%)
NL NYSE NASDAQ 100
Healthcare Medical - Diagnostics & Research
Address
Hulsterweg 82 5912 PL
Venlo, LI, NL
Venlo, LI, NL
CEO
Thierry Bernard
Website
qiagen.com
IPO
1996-06-28
CIK 1015820 ISIN NL0015002SN0
Also trades on
Deutsche Börse · QIA.DE (EUR)
New York Stock Exchange · QGEN (USD)
Description
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Index membership
| Index | Added | Removed | Status |
|---|---|---|---|
| NASDAQ 100 | 2009-12-21 | — | Active |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD41.59
+0.03 (+0.06%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.66
Float Shares
204.90M
Free Float %
99.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.28% | +0.12% | -17.58% | -33.73% | -24.32% | -28.81% | -21.55% | -25.80% | -27.71% | +51.32% | +1,602.02% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (30 ratings, all time)
Hold
Price Targets & DCF
Current price
41.59
Low
38.00
-8.6%
Consensus
47.50
+14.2%
Median
46.50
+11.8%
High
59.00
+41.9%
DCF (Unlevered)
78.72
+89.3%
DCF (Levered)
108.68
+161.3%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
53% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | -1 |
| Buy | 6 | +1 |
| Hold | 8 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 4 |
42.00
+1.0%
|
| Last Quarter | 4 |
42.00
+1.0%
|
| Last Year | 12 |
50.64
+21.8%
|
| All Time | 19 |
52.11
+25.3%
|
Quality scores
Altman Z-Score
3.20
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Diagnostics & Research: +7.9%+5.7% Q1'26: +1.8% (vs Q1'25)
-
EPS growth Medical - Diagnostics & Research: +30.8%+436.8% ★ Q1'26: -19.5% (vs Q1'25)
-
FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%+18.7% ★ Q1'26: +10.9% (vs Q1'25)
-
EBIT margin Medical - Diagnostics & Research: +9.6%+25.1% ★ Q1'26: +23.8% (vs Q1'25)
-
ROIC Medical - Diagnostics & Research: +5.2%+10.5% ★ Q1'26: +8.6% (vs Q1'25)
-
Share dilution Medical - Diagnostics & Research: 0.0%-4.8% ★ Q1'26: -5.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×2.31× Q1'26: 2.44× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 11 Rev. Ana. 8 EPS Ana. |
Dec 2027 12 Rev. Ana. 8 EPS Ana. |
Dec 2028 12 Rev. Ana. 4 EPS Ana. |
Dec 2029 11 Rev. Ana. 2 EPS Ana. |
Dec 2030 6 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.17B
est: 1.17B (-0.2%)
|
1.25B
est: 1.19B (+5.5%)
|
1.30B
est: 1.32B (-1.3%)
|
1.34B
est: 1.40B (-4.2%)
|
1.28B
est: 1.28B (-0.2%)
|
1.34B
est: 1.34B (-0.4%)
|
1.42B
est: 1.42B (+0.2%)
|
1.50B
est: 1.51B (-0.5%)
|
1.53B
est: 1.52B (+0.3%)
|
1.87B
est: 1.85B (+1.2%)
|
2.25B
est: 2.20B (+2.5%)
|
2.14B
est: 2.13B (+0.3%)
|
1.97B
est: 1.94B (+1.3%)
|
1.98B
est: 1.98B (-0.1%)
|
2.09B
est: 2.08B (+0.6%)
|
2.16B
2.12B – 2.21B
+3.9% YoY
|
2.27B
2.20B – 2.33B
+5.3% YoY
|
2.40B
2.38B – 2.41B
+5.4% YoY
|
2.56B
2.51B – 2.62B
+6.9% YoY
|
2.65B
2.60B – 2.72B
+3.6% YoY
|
| EBITDA |
288.95M
est: 292.27M (-1.1%)
|
366.50M
est: 347.41M (+5.5%)
|
267.58M
est: 270.72M (-1.2%)
|
359.50M
est: 370.13M (-2.9%)
|
365.17M
est: 365.02M (+0.0%)
|
308.99M
est: 293.92M (+5.1%)
|
380.51M
est: 365.89M (+4.0%)
|
499.47M
est: 478.58M (+4.4%)
|
227.87M
est: 215.33M (+5.8%)
|
715.80M
est: 647.36M (+10.6%)
|
895.24M
est: 806.96M (+10.9%)
|
779.36M
est: 808.43M (-3.6%)
|
688.56M
est: 636.86M (+8.1%)
|
368.26M
est: 649.78M (-43.3%)
|
717.27M
est: 681.77M (+5.2%)
|
708.29M
694.36M – 726.45M
+3.9% YoY
|
745.94M
723.24M – 765.40M
+5.3% YoY
|
786.17M
780.63M – 791.70M
+5.4% YoY
|
840.08M
823.55M – 861.62M
+6.9% YoY
|
869.98M
852.86M – 892.28M
+3.6% YoY
|
| EBIT |
121.57M
est: 102.55M (+18.5%)
|
168.61M
est: 161.18M (+4.6%)
|
68.22M
est: 64.53M (+5.7%)
|
158.72M
est: 164.14M (-3.3%)
|
173.70M
est: 177.40M (-2.1%)
|
95.93M
est: 94.95M (+1.0%)
|
164.06M
est: 148.57M (+10.4%)
|
293.03M
est: 256.25M (+14.4%)
|
-3.59M
est: -29.06M (+87.6%)
|
510.79M
est: 345.36M (+47.9%)
|
680.31M
est: 249.35M (+172.8%)
|
570.96M
est: 582.92M (-2.1%)
|
483.22M
est: 445.67M (+8.4%)
|
164.99M
est: 454.71M (-63.7%)
|
523.52M
est: 477.10M (+9.7%)
|
495.66M
485.91M – 508.36M
+3.9% YoY
|
522.01M
506.12M – 535.62M
+5.3% YoY
|
550.15M
546.28M – 554.03M
+5.4% YoY
|
587.89M
576.32M – 602.95M
+6.9% YoY
|
608.81M
596.83M – 624.41M
+3.6% YoY
|
| Net Income |
96.04M
est: 97.23M (-1.2%)
|
129.51M
est: 122.74M (+5.5%)
|
69.07M
est: 69.25M (-0.2%)
|
116.37M
est: 120.80M (-3.7%)
|
130.15M
est: 128.78M (+1.1%)
|
80.40M
est: 76.78M (+4.7%)
|
40.39M
est: 40.49M (-0.2%)
|
190.38M
est: 182.88M (+4.1%)
|
-41.46M
est: -42.08M (+1.5%)
|
359.19M
est: 328.72M (+9.3%)
|
512.60M
est: 461.91M (+11.0%)
|
423.21M
est: 468.16M (-9.6%)
|
341.30M
est: 68.30M (+399.7%)
|
83.59M
est: 487.04M (-82.8%)
|
424.88M
est: 505.99M (-16.0%)
|
506.96M
493.48M – 520.43M
+0.2% YoY
|
552.12M
527.49M – 576.75M
+8.9% YoY
|
592.64M
531.34M – 754.17M
+7.3% YoY
|
649.62M
633.00M – 671.27M
+9.6% YoY
|
687.31M
669.73M – 710.21M
+5.8% YoY
|
| SGA |
492.84M
est: 490.43M (+0.5%)
|
495.62M
est: 468.98M (+5.7%)
|
570.60M
est: 576.66M (-1.1%)
|
503.42M
est: 526.36M (-4.4%)
|
464.84M
est: 467.85M (-0.6%)
|
530.60M
est: 498.23M (+6.5%)
|
575.66M
est: 550.51M (+4.6%)
|
533.50M
est: 510.34M (+4.5%)
|
504.17M
est: 499.20M (+1.0%)
|
525.36M
est: 466.70M (+12.6%)
|
584.47M
est: 526.26M (+11.1%)
|
603.95M
est: 544.25M (+11.0%)
|
579.17M
est: 543.58M (+6.5%)
|
564.36M
est: 554.61M (+1.8%)
|
583.67M
est: 581.92M (+0.3%)
|
604.55M
592.66M – 620.05M
+3.9% YoY
|
636.69M
617.31M – 653.30M
+5.3% YoY
|
671.02M
666.30M – 675.74M
+5.4% YoY
|
717.04M
702.93M – 735.42M
+6.9% YoY
|
742.56M
727.95M – 761.59M
+3.6% YoY
|
| EPS |
0.43
est: 0.95 (-54.7%)
|
0.57
est: 0.95 (-40.0%)
|
0.31
est: 1.08 (-71.3%)
|
0.52
est: 1.12 (-53.6%)
|
0.57
est: 1.14 (-50.1%)
|
0.36
est: 1.18 (-69.5%)
|
0.18
est: 1.32 (-86.4%)
|
0.84
est: 1.41 (-40.4%)
|
-0.19
est: 1.47 (-112.9%)
|
0.33
est: 2.24 (-85.2%)
|
2.52
est: 2.66 (-5.1%)
|
2.08
est: 2.44 (-14.8%)
|
1.67
est: 0.33 (+410.4%)
|
0.39
est: 2.34 (-83.3%)
|
2.04
est: 2.39 (-14.8%)
|
2.45
2.37 – 2.50
+2.4% YoY
|
2.66
2.54 – 2.77
+8.2% YoY
|
2.88
2.56 – 3.63
+8.6% YoY
|
3.12
3.04 – 3.23
+8.3% YoY
|
3.31
3.22 – 3.42
+5.8% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-07 | TD Cowen | Hold | Hold | Maintain |
| 2026-04-29 | Citigroup | Neutral | Neutral | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-05 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-04 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-01 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
443.58M
OE per share TTM
2.07
Owner's Yield
6.49%
Maintenance CapEx ratio
64.42%
Maint CapEx / Avg PPE
34.4%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
83
Total invested
208.06M
Insider transactions (90d)
0
Beneficial owners (>5%)
17
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Edward C. Johnson 3d | 29.30M | 12.94% | — | — | 29.30M | — | IN | Delaware | 2010-02-16 | ↗ |
| 2 | BlackRock, Inc. | 22.85M | 10.20% | 21.04M | — | 22.85M | — | HC | Delaware | 2024-11-07 | ↗ |
| 3 | (1)Names of reporting persons. BlackRock, Inc. | 22.28M | 9.95% | — | — | 22.28M | — | HC | Delaware | 2024-10-21 | ↗ |
| 4 | Abigail P. Johnson | 22.00M | 15.01% | — | — | 22.00M | — | IN | United States of America | 2005-02-14 | ↗ |
| 5 | Wellington Group Holdings LLP | 21.25M | 9.49% | — | 16.33M | — | — | HC | Massachusetts | 2024-11-08 | ↗ |
| 6 | Wellington Investment Advisors Holdings LLP | 21.25M | 9.49% | — | 16.33M | — | — | HC | Massachusetts | 2024-11-08 | ↗ |
| 7 | Wellington Management Group LLP | 21.25M | 9.49% | — | 16.33M | — | — | HC | Massachusetts | 2024-11-08 | ↗ |
| 8 | 04-2747644 | 20.46M | 9.00% | 17.33M | — | 20.46M | — | IA | Delaware | 2022-02-02 | ↗ |
| 9 | PRIMECAP Management Company 95-3868081 | 19.14M | 7.99% | 9.24M | — | 19.14M | — | IA | 177 E. Colorado Blvd., 11th Floor, Pasadena, CA 91105 | 2017-02-09 | ↗ |
| 10 | FMR Corp. | 18.43M | 12.30% | 9.86M | — | 18.43M | — | HC | Delaware | 2007-02-14 | ↗ |
| 11 | Anthony A. Yoseloff | 18.25M | 7.98% | — | 18.25M | — | 11.00 | IN | — | 2020-08-03 | ↗ |
| 12 | Burlington Loan Management DAC | 18.25M | 7.98% | — | 18.25M | — | 11.00 | OO | — | 2020-08-03 | ↗ |
| 13 | Davidson Kempner Capital Management LP | 18.25M | 7.98% | — | 18.25M | — | 11.00 | PN | — | 2020-08-03 | ↗ |
| 14 | Wellington Management Company LLP | 13.69M | 6.11% | — | 12.79M | — | — | IA | Massachusetts | 2024-11-08 | ↗ |
| 15 | 94-3359302 | 7.28M | 4.98% | — | — | — | — | PN | California | 2004-02-13 | ↗ |
| 16 | Deutsche Bank A.G. | 3.78M | 11.20% | 37.9K | 3.23M | 37.9K | 3.74M | BK, HC, CO | Federal Republic of Germany | 2000-02-14 | ↗ |
| 17 | Deutsche Gesellschaft fur Wertpapiersparen (DWS) Group | 839.0K | 5.20% | — | 839.0K | — | 839.0K | HC, CO | Federal Republic of Germany | 1999-01-29 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
83
-225 vs prev Q
New positions
28
Closed positions
242
Increased
40
Reduced
42
Put/Call ratio
0.00
Calls held
50.0K
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 510.5K +510.5K (+100.0%) | 22.96B +23.0B (+100.0%) | 0.23% +0.233 pp | 0.58% +0.585 pp | USD47.34 +0.0% | 1 qtrs NEW |
| 2 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 24.21M +264.9K (+1.1%) | 1.09B +18.9M (+1.8%) | 11.07% +0.581 pp | 0.35% +0.020 pp | USD40.23 +17.7% | 4 qtrs — |
| 3 | WELLINGTON MANAGEMENT GROUP LLP | 14.14M -9.2M (-39.4%) | 640.96M -394.9M (-38.1%) | 6.46% -3.755 pp | 0.11% -0.069 pp | USD40.63 +16.5% | 4 qtrs — |
| 4 | VANGUARD GROUP INC | 9.54M +118.1K (+1.3%) | 433.87M +13.5M (+3.2%) | 4.36% +0.235 pp | 0.01% +0.000 pp | USD40.63 +16.5% | 4 qtrs — |
| 5 | DEUTSCHE BANK AG\ | 7.91M +697.3K (+9.7%) | 355.61M +33.5M (+10.4%) | 3.62% +0.457 pp | 0.12% +0.008 pp | USD42.72 +10.8% | 4 qtrs — |
| 6 | BLACKROCK, INC. | 5.40M +93.3K (+1.8%) | 242.98M +5.7M (+2.4%) | 2.47% +0.145 pp | 0.00% +0.000 pp | USD40.27 +17.6% | 4 qtrs — |
| 7 | MORGAN STANLEY | 4.31M -69.7K (-1.6%) | 193.68M -1.9M (-1.0%) | 1.97% +0.052 pp | 0.01% 0.000 pp | USD42.69 +10.9% | 4 qtrs — |
| 8 | AMUNDI | 4.23M -57.6K (-1.3%) | 190.35M -11.1M (-5.5%) | 1.94% +0.056 pp | 0.05% -0.013 pp | USD40.34 +17.4% | 4 qtrs — |
| 9 | EARNEST PARTNERS LLC | 4.19M -20.5K (-0.5%) | 188.33M +298.2K (+0.2%) | 1.91% +0.071 pp | 0.81% -0.009 pp | USD40.90 +15.7% | 4 qtrs — |
| 10 | BOSTON PARTNERS | 3.98M -35.6K (-0.9%) | 179.01M -444.6K (-0.2%) | 1.82% +0.061 pp | 0.19% +0.001 pp | USD44.68 +6.0% | 2 qtrs — |
| 11 | NORGES BANK | 3.65M +3.7M (+100.0%) | 166.50M +166.5M (+100.0%) | 1.67% +1.670 pp | 0.02% +0.018 pp | USD47.34 +0.0% | 1 qtrs NEW |
| 12 | BANK OF AMERICA CORP /DE/ | 3.67M +394.1K (+12.0%) | 164.86M +18.7M (+12.8%) | 1.68% +0.243 pp | 0.01% +0.002 pp | USD40.98 +15.5% | 4 qtrs — |
| 13 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 3.16M +290.4K (+10.1%) | 143.02M +9.9M (+7.4%) | 1.45% +0.188 pp | 0.23% +0.018 pp | USD41.73 +13.4% | 4 qtrs — |
| 14 | CAPITAL INTERNATIONAL INVESTORS | 2.59M +264.4K (+11.4%) | 116.36M +12.6M (+12.1%) | 1.18% +0.166 pp | 0.02% +0.002 pp | USD41.41 +14.3% | 4 qtrs — |
| 15 | STATE STREET CORP | 2.16M -2.4K (-0.1%) | 97.26M +521.0K (+0.5%) | 0.99% +0.041 pp | 0.00% 0.000 pp | USD40.20 +17.8% | 4 qtrs — |
| 16 | SEI INVESTMENTS CO | 1.96M +57.1K (+3.0%) | 88.11M +3.1M (+3.7%) | 0.90% +0.063 pp | 0.09% -0.004 pp | USD40.93 +15.7% | 4 qtrs — |
| 17 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 1.77M -559.6K (-24.0%) | 80.99M -22.4M (-21.7%) | 0.81% -0.211 pp | 0.13% -0.040 pp | USD42.18 +12.2% | 4 qtrs — |
| 18 | BARCLAYS PLC | 1.54M +452.8K (+41.7%) | 69.24M +20.7M (+42.6%) | 0.70% +0.228 pp | 0.02% +0.004 pp | USD42.66 +11.0% | 4 qtrs — |
| 19 | LEGAL & GENERAL GROUP PLC | 1.40M -40.2K (-2.8%) | 63.64M -16.5K (0.0%) | 0.64% +0.009 pp | 0.01% 0.000 pp | USD40.41 +17.1% | 4 qtrs — |
| 20 | NATIXIS ADVISORS, L.P. | 1.41M +103.0K (+7.9%) | 63.49M +5.0M (+8.6%) | 0.65% +0.072 pp | 0.09% +0.005 pp | USD43.41 +9.1% | 4 qtrs — |
| 21 | CITIGROUP INC | 1.41M +1.2M (+493.0%) | 63.45M +52.8M (+496.9%) | 0.65% +0.541 pp | 0.03% +0.023 pp | USD46.13 +2.6% | 4 qtrs — |
| 22 | DIMENSIONAL FUND ADVISORS LP | 1.38M +78.3K (+6.0%) | 61.99M +3.9M (+6.7%) | 0.63% +0.061 pp | 0.01% +0.001 pp | USD44.83 +5.6% | 2 qtrs — |
| 23 | CAISSE DES DEPOTS ET CONSIGNATIONS | 1.35M +— (+0.0%) | 61.41M +1.9M (+3.2%) | 0.62% +0.026 pp | 1.40% -1.130 pp | USD40.15 +17.9% | 4 qtrs — |
| 24 | INVESCO LTD. | 1.29M -10.2K (-0.8%) | 57.95M -81.8K (-0.1%) | 0.59% +0.020 pp | 0.01% 0.000 pp | USD44.56 +6.2% | 4 qtrs — |
| 25 | BNP PARIBAS ARBITRAGE, SNC | 1.18M +20.6K (+1.8%) | 53.04M +1.3M (+2.4%) | 0.54% +0.032 pp | 0.02% -0.004 pp | USD40.65 +16.5% | 4 qtrs — |
| 26 | UBS GROUP AG | 1.15M +804.1K (+230.2%) | 51.87M +36.3M (+232.3%) | 0.53% +0.374 pp | 0.01% +0.006 pp | USD45.16 +4.8% | 4 qtrs — |
| 27 | NORTHERN TRUST CORP | 1.10M -142.1K (-11.4%) | 49.41M -6.0M (-10.9%) | 0.50% -0.041 pp | 0.01% -0.001 pp | USD40.61 +16.6% | 4 qtrs — |
| 28 | ALLIANZ ASSET MANAGEMENT GMBH | 1.08M -451.3K (-29.5%) | 49.26M -18.8M (-27.6%) | 0.49% -0.177 pp | 0.05% -0.026 pp | USD45.78 +3.4% | 4 qtrs — |
| 29 | GEODE CAPITAL MANAGEMENT, LLC | 1.09M -14.9K (-1.4%) | 49.22M +30.6K (+0.1%) | 0.50% +0.014 pp | 0.00% 0.000 pp | USD40.29 +17.5% | 4 qtrs — |
| 30 | ILEX CAPITAL PARTNERS (UK) LLP | 1.02M +1.0M (+100.0%) | 46.58M +46.6M (+100.0%) | 0.47% +0.467 pp | 1.31% +1.315 pp | USD47.34 +0.0% | 1 qtrs NEW |
| 31 | DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 1.00M -1.2M (-53.6%) | 45.00M -50.5M (-52.9%) | 0.46% -0.487 pp | 0.04% -0.045 pp | USD40.75 +16.2% | 4 qtrs — |
| 32 | CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 932.3K +320.9K (+52.5%) | 42.54M +15.5M (+57.1%) | 0.43% +0.159 pp | 0.07% +0.023 pp | USD45.60 +3.8% | 2 qtrs — |
| 33 | FIL LTD | 897.1K +76.7K (+9.4%) | 40.41M +3.8M (+10.4%) | 0.41% +0.051 pp | 0.03% +0.002 pp | USD42.76 +10.7% | 4 qtrs — |
| 34 | BANK OF NEW YORK MELLON CORP | 897.8K -11.9K (-1.3%) | 40.38M -269.5K (-0.7%) | 0.41% +0.012 pp | 0.01% -0.001 pp | USD40.56 +16.7% | 4 qtrs — |
| 35 | JPMORGAN CHASE & CO | 886.8K +146.2K (+19.7%) | 39.88M +6.8M (+20.5%) | 0.41% +0.081 pp | 0.00% +0.001 pp | USD44.90 +5.4% | 4 qtrs — |
| 36 | PICTET ASSET MANAGEMENT HOLDING SA | 860.8K -678.3K (-44.1%) | 39.28M -28.9M (-42.4%) | 0.39% -0.281 pp | 0.04% -0.028 pp | USD40.99 +15.5% | 4 qtrs — |
| 37 | NUANCE INVESTMENTS, LLC | 803.6K +264.8K (+49.1%) | 36.14M +12.1M (+50.1%) | 0.37% +0.131 pp | 3.98% +1.531 pp | USD42.52 +11.3% | 4 qtrs — |
| 38 | NUVEEN, LLC | 779.6K -261.2K (-25.1%) | 35.31M -11.0M (-23.8%) | 0.36% -0.099 pp | 0.01% -0.003 pp | USD40.17 +17.8% | 4 qtrs — |
| 39 | DNCA FINANCE | 691.8K +133.3K (+23.9%) | 31.57M +6.8M (+27.6%) | 0.32% +0.072 pp | 1.83% +0.135 pp | USD47.73 -0.8% | 3 qtrs — |
| 40 | FMR LLC | 596.3K +118.2K (+24.7%) | 27.21M +6.0M (+28.5%) | 0.27% +0.063 pp | 0.00% +0.000 pp | USD42.59 +11.2% | 4 qtrs — |
| 41 | SWISS NATIONAL BANK | 591.1K -35.1K (-5.6%) | 26.94M -754.1K (-2.7%) | 0.27% -0.004 pp | 0.02% +0.000 pp | USD40.59 +16.6% | 4 qtrs — |
| 42 | LMR PARTNERS LLP | 550.0K +450.0K (+450.0%) | 24.80M +20.4M (+458.0%) | 0.25% +0.208 pp | 0.05% +0.027 pp | USD46.92 +0.9% | 4 qtrs — |
| 43 | GOLDMAN SACHS GROUP INC | 501.7K +278.6K (+124.9%) | 22.56M +12.6M (+126.4%) | 0.23% +0.132 pp | 0.00% +0.002 pp | USD45.87 +3.2% | 4 qtrs — |
| 44 | PARKMAN HEALTHCARE PARTNERS LLC | 494.4K -5.8K (-1.2%) | 22.23M -116.1K (-0.5%) | 0.23% +0.007 pp | 2.12% -0.215 pp | USD42.36 +11.8% | 4 qtrs — |
| 45 | CAPITAL INTERNATIONAL, INC./CA/ | 474.1K -32.4K (-6.4%) | 21.32M -1.3M (-5.8%) | 0.22% -0.005 pp | 0.17% -0.013 pp | USD47.91 -1.2% | 3 qtrs — |
| 46 | BALYASNY ASSET MANAGEMENT L.P. | 436.8K -417.6K (-48.9%) | 19.64M -18.5M (-48.5%) | 0.20% -0.175 pp | 0.02% -0.023 pp | USD42.95 +10.2% | 4 qtrs — |
| 47 | CITADEL ADVISORS LLC | 432.2K +131.2K (+43.6%) | 19.44M +6.0M (+44.5%) | 0.20% +0.066 pp | 0.00% +0.001 pp | USD42.33 +11.8% | 4 qtrs — |
| 48 | BARINGS LLC | 407.3K +— (+0.0%) | 18.57M +547.4K (+3.0%) | 0.19% +0.008 pp | 0.34% -0.001 pp | USD40.15 +17.9% | 4 qtrs — |
| 49 | AQR CAPITAL MANAGEMENT LLC | 398.0K +289.2K (+265.8%) | 18.06M +13.2M (+271.4%) | 0.18% +0.134 pp | 0.01% +0.006 pp | USD45.37 +4.3% | 4 qtrs — |
| 50 | PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 349.6K +— (+0.0%) | 15.72M +101.0K (+0.6%) | 0.16% +0.007 pp | 0.06% +0.000 pp | USD40.15 +17.9% | 4 qtrs — |
| 51 | TWO SIGMA INVESTMENTS, LP | 331.9K +331.9K (+100.0%) | 14.93M +14.9M (+100.0%) | 0.15% +0.152 pp | 0.02% +0.021 pp | USD47.34 +0.0% | 1 qtrs NEW |
| 52 | MOORS & CABOT, INC. | 330.7K -22.1K (-6.3%) | 14.87M -889.8K (-5.6%) | 0.15% -0.003 pp | 0.64% -0.051 pp | USD44.70 +5.9% | 4 qtrs — |
| 53 | RUSSELL INVESTMENTS GROUP, LTD. | 274.6K -88.0K (-24.3%) | 12.50M -3.6M (-22.3%) | 0.13% -0.033 pp | 0.01% -0.005 pp | USD42.82 +10.6% | 4 qtrs — |
| 54 | FIRST TRUST ADVISORS LP | 270.0K +185.3K (+218.7%) | 12.14M +8.4M (+220.7%) | 0.12% +0.086 pp | 0.01% +0.006 pp | USD47.45 -0.2% | 3 qtrs — |
| 55 | RAYMOND JAMES FINANCIAL INC | 253.7K -8.4K (-3.2%) | 11.41M -299.9K (-2.6%) | 0.12% +0.001 pp | 0.00% 0.000 pp | USD41.41 +14.3% | 4 qtrs — |
| 56 | AVIVA PLC | 247.1K +13.2K (+5.7%) | 11.27M +963.0K (+9.3%) | 0.11% +0.011 pp | 0.02% +0.000 pp | USD40.54 +16.8% | 4 qtrs — |
| 57 | BANK OF MONTREAL /CAN/ | 249.7K -5.1K (-2.0%) | 11.23M -153.4K (-1.3%) | 0.11% +0.003 pp | 0.00% -0.001 pp | USD41.07 +15.3% | 4 qtrs — |
| 58 | NITORUM CAPITAL, L.P. | 244.8K -14.8K (-5.7%) | 11.01M -588.6K (-5.1%) | 0.11% -0.002 pp | 2.43% +0.397 pp | USD45.24 +4.6% | 4 qtrs — |
| 59 | QUANTINNO CAPITAL MANAGEMENT LP | 222.8K +34.9K (+18.6%) | 10.06M +1.7M (+20.1%) | 0.10% +0.020 pp | 0.02% -0.003 pp | USD45.24 +4.6% | 4 qtrs — |
| 60 | ALLIANCEBERNSTEIN L.P. | 213.8K +13.5K (+6.7%) | 9.61M +663.2K (+7.4%) | 0.10% +0.010 pp | 0.00% +0.000 pp | USD43.05 +10.0% | 4 qtrs — |
| 61 | ORIBEL CAPITAL MANAGEMENT, LP | 213.2K +213.2K (+100.0%) | 9.59M +9.6M (+100.0%) | 0.10% +0.098 pp | 0.44% +0.439 pp | USD47.34 +0.0% | 1 qtrs NEW |
| 62 | STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 204.4K -17.4K (-7.8%) | 9.19M -716.5K (-7.2%) | 0.09% -0.004 pp | 0.02% -0.001 pp | USD40.22 +17.7% | 4 qtrs — |
| 63 | VOYA INVESTMENT MANAGEMENT LLC | 201.3K +18.4K (+10.1%) | 9.07M +910.7K (+11.2%) | 0.09% +0.012 pp | 0.01% +0.001 pp | USD42.55 +11.3% | 4 qtrs — |
| 64 | TREASURER OF THE STATE OF NORTH CAROLINA | 197.8K -6.7K (-3.3%) | 8.90M -243.0K (-2.7%) | 0.09% +0.001 pp | 0.03% +0.000 pp | USD42.48 +11.4% | 4 qtrs — |
| 65 | RHUMBLINE ADVISERS | 186.0K -6.3K (-3.3%) | 8.37M -226.4K (-2.6%) | 0.09% +0.001 pp | 0.01% 0.000 pp | USD40.36 +17.3% | 4 qtrs — |
| 66 | FRANKLIN RESOURCES INC | 179.8K -885.0 (-0.5%) | 8.16M +161.6K (+2.0%) | 0.08% +0.003 pp | 0.00% +0.000 pp | USD40.15 +17.9% | 4 qtrs — |
| 67 | AMERICAN CENTURY COMPANIES INC | 180.7K +118.6K (+190.7%) | 8.13M +5.4M (+192.6%) | 0.08% +0.055 pp | 0.00% +0.003 pp | USD47.40 -0.1% | 4 qtrs — |
| 68 | QUANTBOT TECHNOLOGIES LP | 178.9K +174.5K (+4,012.3%) | 8.04M +7.9M (+4,039.0%) | 0.08% +0.080 pp | 0.27% +0.262 pp | USD47.36 0.0% | 3 qtrs — |
| 69 | EDGESTREAM PARTNERS, L.P. | 176.8K +63.1K (+55.5%) | 7.95M +2.9M (+56.5%) | 0.08% +0.031 pp | 0.22% +0.075 pp | USD45.63 +3.7% | 4 qtrs — |
| 70 | JANE STREET GROUP, LLC | 172.7K -229.5K (-57.1%) | 7.77M -10.2M (-56.8%) | 0.08% -0.097 pp | 0.00% -0.002 pp | USD44.76 +5.8% | 4 qtrs — |
| 71 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 169.1K +84.5K (+99.9%) | 7.62M +3.9M (+102.4%) | 0.08% +0.040 pp | 0.01% +0.005 pp | USD43.74 +8.2% | 4 qtrs — |
| 72 | VAN ECK ASSOCIATES CORP | 153.6K -29.7K (-16.2%) | 6.91M -1.3M (-15.7%) | 0.07% -0.010 pp | 0.01% -0.002 pp | USD40.72 +16.3% | 4 qtrs — |
| 73 | SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 144.7K +— (+0.0%) | 6.51M +42.0K (+0.6%) | 0.07% +0.003 pp | 0.22% -0.031 pp | USD46.77 +1.2% | 4 qtrs — |
| 74 | POINT72 ASSET MANAGEMENT, L.P. | 144.0K +144.0K (+100.0%) | 6.48M +6.5M (+100.0%) | 0.07% +0.066 pp | 0.01% +0.007 pp | USD47.34 +0.0% | 1 qtrs NEW |
| 75 | STATE OF ALASKA, DEPARTMENT OF REVENUE | 142.2K +— (+0.0%) | 6.39M +42.0K (+0.7%) | 0.07% +0.003 pp | 0.07% +0.003 pp | USD40.15 +17.9% | 4 qtrs — |
| 76 | LIONTRUST INVESTMENT PARTNERS LLP | 138.0K -74.4K (-35.0%) | 6.30M -3.1M (-33.1%) | 0.06% -0.030 pp | 0.09% -0.039 pp | USD48.06 -1.5% | 3 qtrs — |
| 77 | ZACKS INVESTMENT MANAGEMENT | 132.3K -2.9K (-2.1%) | 6.26M +266.8K (+4.5%) | 0.06% +0.001 pp | 0.05% +0.001 pp | USD48.04 -1.5% | 3 qtrs — |
| 78 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 138.8K -24.2K (-14.9%) | 6.24M -1.0M (-14.3%) | 0.06% -0.008 pp | 0.00% -0.001 pp | USD44.68 +6.0% | 2 qtrs — |
| 79 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 132.2K +109.0K (+469.8%) | 5.95M +4.9M (+473.5%) | 0.06% +0.050 pp | 0.00% +0.001 pp | USD46.89 +1.0% | 4 qtrs — |
| 80 | GROUPE LA FRANCAISE | 124.4K -18.4K (-12.9%) | 5.68M -649.0K (-10.3%) | 0.06% -0.006 pp | 0.08% -0.006 pp | USD42.29 +11.9% | 4 qtrs — |
| 81 | NEW YORK STATE COMMON RETIREMENT FUND | 122.5K +— (+0.0%) | 5.51M +35.5K (+0.6%) | 0.06% +0.002 pp | 0.01% +0.000 pp | USD40.22 +17.7% | 4 qtrs — |
| 82 | CREDIT AGRICOLE S A | 121.4K +56.2K (+86.1%) | 5.46M +2.5M (+87.3%) | 0.06% +0.027 pp | 0.01% +0.005 pp | USD45.91 +3.1% | 2 qtrs — |
| 83 | PUBLIC SECTOR PENSION INVESTMENT BOARD | 109.2K -17.4K (-13.7%) | 4.98M -628.5K (-11.2%) | 0.05% -0.006 pp | 0.02% -0.004 pp | USD40.63 +16.5% | 4 qtrs — |
| 84 | ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 108.9K +14.7K (+15.6%) | 4.95M +789.5K (+19.0%) | 0.05% +0.009 pp | 0.01% +0.001 pp | USD41.47 +14.2% | 4 qtrs — |
| 85 | SIH PARTNERS, LLLP | 104.6K -17.1K (-14.1%) | 4.70M -733.7K (-13.5%) | 0.05% -0.006 pp | 0.09% -0.066 pp | USD44.14 +7.2% | 4 qtrs — |
| 86 | OAK HARVEST INVESTMENT SERVICES | 98.7K +14.8K (+17.7%) | 4.44M +691.9K (+18.5%) | 0.05% +0.008 pp | 0.48% +0.047 pp | USD41.51 +14.0% | 4 qtrs — |
| 87 | PERBAK CAPITAL PARTNERS LLP | 96.1K -8.7K (-8.3%) | 4.32M -362.8K (-7.7%) | 0.04% -0.002 pp | 1.32% +0.494 pp | USD45.46 +4.1% | 4 qtrs — |
| 88 | KOREA INVESTMENT CORP | 93.0K -61.7K (-39.9%) | 4.24M -2.6M (-38.1%) | 0.04% -0.025 pp | 0.01% -0.006 pp | USD45.61 +3.8% | 4 qtrs — |
| 89 | LAZARD ASSET MANAGEMENT LLC | 93.7K -268.6K (-74.1%) | 4.23M -11.9M (-73.8%) | 0.04% -0.116 pp | 0.01% -0.015 pp | USD44.68 +6.0% | 2 qtrs — |
| 90 | SIEMENS FONDS INVEST GMBH | 107.3K -22.6K (-17.4%) | 4.17M -726.3K (-14.8%) | 0.05% -0.008 pp | 0.22% -0.046 pp | USD40.15 +17.9% | 4 qtrs — |
| 91 | PORTOLAN CAPITAL MANAGEMENT, LLC | 90.2K +90.2K (+100.0%) | 4.06M +4.1M (+100.0%) | 0.04% +0.041 pp | 0.22% +0.217 pp | USD47.34 +0.0% | 1 qtrs NEW |
| 92 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 88.8K +5.5K (+6.7%) | 3.99M +273.7K (+7.4%) | 0.04% +0.004 pp | 0.00% +0.000 pp | USD45.07 +5.0% | 4 qtrs — |
| 93 | SCULPTOR CAPITAL LP | 150.0K +150.0K (+100.0%) | 54.6K +54.6K (+100.0%) | 0.07% +0.069 pp | 0.00% +0.001 pp | USD47.34 +0.0% | 1 qtrs NEW |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 22 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Global X - Genomics & Biotechnology ETF GNOM | 3.52% | 3.06M | 0.50% |
| 2 | First Trust Health Care AlphaDEX Fund FXH | 1.84% | 18.35M | 0.61% |
| 3 | ROBO Global Robotics and Automation Index ETF ROBO | 1.24% | 22.77M | 0.95% |
| 4 | VanEck Biotech ETF BBH | 1.12% | 4.47M | 0.35% |
| 5 | Global X - Adaptive U.S. Factor ETF AUSF | 0.51% | 4.39M | 0.27% |
| 6 | State Street SPDR US Large Cap Low Volatility Index ETF LGLV | 0.27% | 3.15M | 0.12% |
| 7 | State Street SPDR Russell 1000 Low Volatility Focus ETF ONEV | 0.25% | 866.1K | 0.20% |
| 8 | WisdomTree BioRevolution UCITS ETF - USD Acc WDNA.L | 0.25% | 55.1K | 0.45% |
| 9 | Optimize Strategy Index ETF OPTZ | 0.22% | 536.2K | 0.25% |
| 10 | State Street SPDR Russell 1000 Yield Focus ETF ONEY | 0.19% | 1.37M | 0.20% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
91.3K
Shares Outstanding
206.07M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Thierry Bernard | Chief Executive Officer, MD & Member of Management Board | 2M | male |
| Roland Sackers | Chief Financial Officer, MD & Member of Management Board | 1M | — |
| Dominic John | Vice President of Marketing & Product Management | — | — |
| Jean-Pascal Viola | Senior Vice President & Head of Corporate Strategy and Business Development | — | male |
| John Gilardi | Vice President & Head of Corporate Communications | — | male |
| Jonathan G. Sheldon | Senior Vice President & Head of the QIAGEN Digital Insights Business Area | — | — |
| Stephany Foster | Senior Vice President & Head of Human Resources | — | female |
| Thomas Schweins | Senior Vice President of Life Science Business Area | — | — |
| Antonio Santos | Senior Vice President & Head of Global Operations | — | male |
| Thomas Theuringer | Senior Director & Head of External Communications | — | — |
| Daniel Wendorff CEFA CIIA | VP & Head of Investor Relations | — | male |
ESG Rating
ESG Score History MEDICAL - DIAGNOSTICS & RESEARCH
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2022-04-13 | 2022-05-06 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
| 2022-02-14 | 2022-03-08 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2020-03-24 | 2020-04-03 | Peter Welch | VT00 | — | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2020-02-27 | 2020-03-10 | Peter Welch | VT00 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2019-10-08 | 2019-11-07 | Alan S. Lowenthal | CA47 | Spouse | Sale (Full) | $50,001 - $100,000 | ↗ |
| 2019-10-08 | 2019-11-08 | Alan S. Lowenthal | CA47 | Spouse | Sale (Full) | $15,001 - $50,000 | ↗ |
| 2019-10-08 | 2019-11-08 | Alan S. Lowenthal | CA47 | Spouse | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2019-09-13 | 2019-09-21 | Alan S. Lowenthal | CA47 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2019-09-12 | 2019-09-21 | Alan S. Lowenthal | CA47 | Spouse | Purchase | $15,001 - $50,000 | ↗ |
| 2019-09-12 | 2019-09-21 | Alan S. Lowenthal | CA47 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2019-01-23 | 2020-04-27 | Donna Shalala | FL27 | -- | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2019-01-09 | 2020-04-27 | Donna Shalala | FL27 | -- | Sale (Full) | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for QGEN
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
